Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Diabetic Neuropathy Clinical Trials

A listing of Diabetic Neuropathy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (35) clinical trials

The purpose of this research study is to test if lidocaine provides effective pain relief for your diabetes-related foot pain. There will be 2 to 3 outpatient study visits over about 7 weeks. This will take about 10 hours total. There will be IV, blood samples, questionnaires, sensory mapping, quantitative ...

Phase N/A

Endeavor Clincial Trials is seeking volunteers to participate in a Diabetic Peripheral Neuropathy (DPN) research study.

Phase N/A

Do you have Diabetic Peripheral Neuropathy?

Phase N/A

This is a randomized, double-blind, parallel-group, placebo-controlled, multiple-dose study to assess the efficacy and safety of NYX-2925 in subjects with neuropathic pain associated with diabetic peripheral neuropathy. The study will be a 6 to 9-week study, including a 1-to 4-week (dependent on duration of washout period) Screening Period, followed by ...

Phase N/A

To demonstrate the analgesic efficacy of PEMF treatment compared to sham treatment in patients with painful diabetic distal peripheral neuropathy when treatment is administered 30 minutes twice daily.

Phase N/A

Out-Patient Clinic in Evansville, Indiana. NO overnight stays. Interested participant must be able to make out-patient visits to the clinic. Device Trial using (PEMF) Pulsed Electromagnetic Field Energy therapy. This device is currently FDA approved for treatment of post-operative pain and edema. Must be able to complete at home, with ...

Phase N/A

Foot and Ankle Mobilisation in Diabetic Peripheral Neuropathy

Diabetes can affect the blood supply to the nerves in the legs. When this occurs a peripheral neuropathy can occur when the nerves carrying sensory information are affected. People with diabetic peripheral neuropathy have a high risk of foot ulceration and amputation which affects function and associated with high NHS ...

Phase N/A

A Real World Observational Registry of Chronic Wounds and Ulcers

This is a longitudinal, observational study of chronic wounds and ulcers treated at participating hospital based, outpatient wound centers. Data collection began in 2005. Structured data are collected at the point of care in the patient electronic health record and data from all patients at more than 100 wound centers ...

Phase N/A

Graded Exposure in Patients With Painful Diabetic Neuropathy

Intervention: Graded Exposure in vivo (GEXP) is a second-generation cognitive-behavioural intervention, and is characterized by systematic and repeated exposure to feared movements, activities and/or sensations in order to decrease fear and subsequently increase physical activity. Main study parameters/endpoints: The purpose of this project is to develop and test a cognitive ...

Phase N/A

Lidocaine for Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathy [DPN] is caused by diabetes-related metabolic damage to the sensory nervous system. It affects more than 3 million Americans and is leading cause of nerve damage-associated pain worldwide. Currently approved drugs such as gabapentin, pregabalin, and duloxetine provide pain relief only in 1 out of 4 or ...

Phase N/A